JPAD-Journal of Prevention of Alzheimers Disease

Scope & Guideline

Shaping Tomorrow’s Solutions Against Alzheimer’s

Introduction

Welcome to your portal for understanding JPAD-Journal of Prevention of Alzheimers Disease, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2274-5807
PublisherSPRINGER BASEL AG
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJPAD-J PREV ALZHEIM / JPAD-J. Prev. Alzheimers Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPICASSOPLATZ 4, BASEL 4052, SWITZERLAND

Aims and Scopes

The Journal of Prevention of Alzheimer's Disease (JPAD) is dedicated to advancing the understanding and prevention of Alzheimer's disease through comprehensive research that encompasses a range of biological, psychological, and social factors. The journal focuses on innovative methodologies and interdisciplinary approaches to address the complexities of Alzheimer's disease and cognitive decline.
  1. Prevention Strategies and Interventions:
    The journal emphasizes the development and evaluation of various prevention strategies aimed at delaying or preventing cognitive decline and Alzheimer's disease. This includes lifestyle modifications, dietary interventions, and community-based programs.
  2. Biomarkers and Diagnostic Tools:
    Research on biomarkers for early detection and diagnosis of Alzheimer's disease is a core focus. This includes studies on blood, imaging, and genetic biomarkers that can help identify individuals at risk and monitor disease progression.
  3. Cognitive Function Assessment:
    JPAD publishes studies that explore cognitive assessments and their relevance in clinical and community settings. This includes the validation of new cognitive tests and the use of digital tools to evaluate cognitive function.
  4. Health Equity and Access:
    The journal addresses disparities in Alzheimer's disease research and treatment, focusing on recruitment strategies for underrepresented populations in clinical trials and the role of social determinants of health.
  5. Innovative Therapeutic Approaches:
    Research into new therapeutic strategies, including pharmacological and non-pharmacological interventions, is a significant area of interest. This includes studies on the efficacy of new drugs, dietary supplements, and lifestyle changes.
  6. Longitudinal Studies and Cohort Analyses:
    JPAD often features longitudinal studies that track cognitive decline over time, providing insights into the progression of Alzheimer's disease and associated risk factors.
The Journal of Prevention of Alzheimer's Disease is witnessing a dynamic shift towards several emerging themes that reflect current trends in Alzheimer's research. These themes highlight innovative approaches and interdisciplinary research efforts.
  1. Digital Health Interventions:
    The use of digital technologies for cognitive assessments, monitoring, and interventions is rapidly gaining traction. Research exploring how mobile applications and online platforms can enhance cognitive health is increasingly prevalent.
  2. Personalized Medicine Approaches:
    There is a growing emphasis on personalized medicine in Alzheimer's research, with studies focusing on tailoring interventions based on individual genetic, lifestyle, and health profiles.
  3. Multidomain Lifestyle Interventions:
    Research on multidomain interventions that combine dietary, physical, and cognitive activities to prevent cognitive decline is on the rise, reflecting an integrated approach to Alzheimer's prevention.
  4. Community Engagement in Research:
    The journal is increasingly highlighting the importance of community engagement in Alzheimer's research, particularly in recruiting diverse populations for clinical trials and addressing health disparities.
  5. Neuroinflammation and Immune Response:
    Emerging research into the role of neuroinflammation and the immune response in Alzheimer's disease is gaining prominence, with studies investigating therapeutic strategies targeting these pathways.
  6. Social Determinants of Health:
    There is an increasing focus on how social determinants, such as socioeconomic status and access to care, impact cognitive health and the progression of Alzheimer's disease.

Declining or Waning

While the Journal of Prevention of Alzheimer's Disease continues to evolve, certain themes have shown a decline in prominence in recent publications. These waning scopes suggest a shift in research priorities and emerging areas of focus.
  1. Historical Epidemiological Studies:
    There has been a noticeable decrease in the publication of traditional epidemiological studies that solely focus on historical data without integrating contemporary methods or innovative approaches.
  2. Single-Factor Risk Assessments:
    Research solely emphasizing single-factor risk assessments for Alzheimer's disease is declining. The trend is moving towards multifactorial approaches that consider a combination of genetic, environmental, and lifestyle factors.
  3. Basic Science Research:
    Studies focused exclusively on basic biological mechanisms of Alzheimer's disease without practical implications for prevention or intervention are becoming less frequent, as the journal emphasizes translational research.
  4. Pharmacological Monotherapy Trials:
    There is a waning interest in studies that evaluate the effectiveness of pharmacological monotherapies for Alzheimer's treatment, as the focus shifts towards combination therapies and holistic approaches.

Similar Journals

Journal of Nutrition Health & Aging

Transforming lives with cutting-edge insights on nutrition and aging.
Publisher: ELSEVIER SCIENCE INCISSN: 1279-7707Frequency: 10 issues/year

Welcome to the Journal of Nutrition Health & Aging, a prestigious publication dedicated to advancing knowledge in the critical fields of nutrition, gerontology, and geriatrics. Published by Elsevier Science Inc, this journal boasts an impressive impact factor and is recognized in the top quartile (Q1) of multiple categories including Geriatrics and Gerontology, Medicine (miscellaneous), and Nutrition and Dietetics. Since its inception in 1997, it has served as a vital platform for researchers, practitioners, and students alike to disseminate innovative research and practical applications relevant to aging populations. With a Scopus rank placing it in the top 15% of its field, it underscores its commitment to high-quality and impactful scholarship. Although it is not an open access journal, its significant reach ensures that valuable insights will continue to inform best practices and policy decisions in health and nutrition. We invite you to explore and contribute to this vital conversation surrounding health and well-being in older adults.

Early Intervention in Psychiatry

Advancing Psychiatry: Where Early Intervention Meets Innovation
Publisher: WILEYISSN: 1751-7885Frequency: 12 issues/year

Early Intervention in Psychiatry, published by WILEY, is an esteemed academic journal dedicated to advancing the field of psychiatry and mental health through rigorous research and innovative practices. Established in 2007 and continuing through 2024, this journal serves as a critical resource for researchers, clinicians, and students interested in the early detection and treatment of psychiatric disorders. With an ISSN of 1751-7885 and an E-ISSN of 1751-7893, it is recognized for its significant contributions, placing in the Q3 quartile in Biological Psychiatry and Q2 in Psychiatry and Mental Health as of 2023. The journal boasts impressive Scopus rankings, being placed 12th in Nursing - Psychiatric Mental Health and 27th in Neuroscience - Biological Psychiatry, showcasing its impact within the scientific community. While not an open-access journal, its findings are pivotal for those seeking to enhance mental health interventions. Early Intervention in Psychiatry is committed to fostering knowledge and improving practices that ultimately contribute to better mental health outcomes globally.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Enhancing understanding of psychiatric disorders in older adults.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

BRAIN

Innovating Insights into Neurological Disorders
Publisher: OXFORD UNIV PRESSISSN: 0006-8950Frequency: 12 issues/year

BRAIN, published by Oxford University Press, stands as a preeminent journal in the realms of neurology and medicine, with a formidable impact factor reflecting its rigorous peer-reviewed standards and significant contributions to the field. With its ISSN 0006-8950 and E-ISSN 1460-2156, this esteemed publication spans over a century of exceptional research, converging from its historical roots in 1878 to current groundbreaking studies. BRAIN boasts a distinguished rank of #8 out of 400 in the Scopus category of Neurology (Clinical), placing it in the 98th percentile of institutions, indicative of its influence and reach. Operating under the Q1 category in both Medicine (Miscellaneous) and Clinical Neurology, the journal is dedicated to fostering interdisciplinary dialogue among researchers, clinicians, and students alike. With a focus on innovative findings and clinical advancements, BRAIN serves as a vital resource for those seeking to deepen their understanding of neurological disorders and the evolving landscape of medical research.

Clinical Interventions in Aging

Pioneering Interventions for Quality Aging
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Clinical Interventions in Aging is a premier Open Access journal published by DOVE MEDICAL PRESS LTD that has been at the forefront of geriatric research since its inception in 2006. With its core focus on innovative interventions and evidence-based practices to enhance the quality of life for the elderly, this journal serves as a vital resource for researchers, healthcare professionals, and students in the fields of geriatrics and gerontology. The journal boasts a commendable impact factor, achieving a Q2 ranking in Geriatrics and Gerontology and a Q1 ranking in Medicine (miscellaneous) as of 2023, highlighting its significant academic contribution. Notably, its Scopus ranking places it in the top 31% of its category, underscoring the relevance and quality of the research it publishes. With a commitment to advancing knowledge, this journal not only promotes accessibility through its Open Access model but also ensures that cutting-edge studies are readily available to those dedicated to improving geriatric care. Located in Auckland, New Zealand, the journal continues to expand its influence globally, making it an essential platform for discussions surrounding aging and health.

GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry

Transforming Perspectives on Geriatric Psychiatry
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 1662-9647Frequency: 4 issues/year

GeroPsych - The Journal of Gerontopsychology and Geriatric Psychiatry, published by HOGREFE AG, stands as an essential academic resource in the evolving fields of gerontology and geriatric psychiatry. With a commitment to advancing the understanding of psychological well-being in older adults, the journal provides a platform for high-quality research, discussion, and innovation that caters to researchers, practitioners, and students alike. Although currently not an open-access publication, GeroPsych ensures accessibility through various academic libraries and institutions, fostering a collaborative approach to the complexities of aging and mental health. Recognized within the Q3 category for Geriatrics and Gerontology, and with its impact reflected in Scopus rankings, this journal plays a pivotal role in informing best practices and shaping policies within the interdisciplinary landscape of geriatric care. Spanning research from 2010 to 2024, GeroPsych is positioned as a leading journal for those committed to improving the mental health and psychological resilience of the aging population.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Illuminating the path to effective Alzheimer's monitoring.
Publisher: WILEYISSN: Frequency: 1 issue/year

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published by WILEY, stands at the forefront of research in the fields of neurology and psychiatry. As an Open Access journal since 2015, it fosters transparency and accessibility in sharing critical knowledge pertaining to the diagnosis, assessment, and monitoring of Alzheimer’s disease and related dementias. With an impressive impact factor reflected in its Q1 rankings in both Neurology (Clinical) and Psychiatry and Mental Health, this journal is recognized for its significant contribution to advancing understanding and improving clinical practices, as evidenced by its Scopus rankings in the top percentiles. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and methodologies that shape the future of dementia care, enhancing both patient outcomes and the scientific community's response to this pressing health challenge. With its headquarters located in Hoboken, NJ, this journal is a pivotal platform for disseminating high-quality, peer-reviewed research that strives to combat one of the most challenging areas in medicine today.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Empowering care through rigorous academic exploration.
Publisher: SAGE PUBLICATIONS INCISSN: 0891-9887Frequency: 6 issues/year

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, published by SAGE PUBLICATIONS INC, is a premier academic journal dedicated to advancing the understanding of mental health issues and neurological disorders in the aging population. With an established presence since 1988, this journal stands out in the fields of Geriatrics, Gerontology, Neurology, and Psychiatry, currently positioned in the Q2 category based on 2023 metrics, reflecting its influence and academic rigor. The journal is indexed in major databases and is highly regarded for its contributions, as evidenced by its strong Scopus rankings. It serves as an essential resource for researchers, clinicians, and students, offering insightful articles that explore the complex interplay between aging, mental health, and neurological conditions. Although it does not provide open access, it continues to be a vital source of scholarly knowledge for those dedicated to enhancing the well-being of the elderly population.

NEUROBIOLOGY OF AGING

Decoding Neurobiological Mechanisms of Aging
Publisher: ELSEVIER SCIENCE INCISSN: 0197-4580Frequency: 6 issues/year

NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Exploring the intersection of geriatrics and cognitive science.
Publisher: KARGERISSN: 1420-8008Frequency: 6 issues/year

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.